# An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors

> **NCT00657176** · PHASE1 · UNKNOWN · sponsor: **Korea Otsuka Pharmaceutical Co., Ltd.** · enrollment: 36 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** OPB-31121

## Key facts

- **NCT ID:** NCT00657176
- **Lead sponsor:** Korea Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2009-03
- **Final completion:** 2009-06
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2008-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00657176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00657176, "An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00657176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*